Oxaliplatin lipidosome
奥沙利铂脂质体
Report date: 2023/03/21 09:17:57
Base Information
Drug NameOxaliplatin lipidosome
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesJiangsu Aosaikang Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesJiangsu Aosaikang Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications